Amphora Discovery

About:

Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry.

Website: http://www.amphoracorp.com/

Top Investors: OrbiMed, 3i Group, Versant Ventures, ARCH Venture Partners, Novartis Venture Fund

Description:

Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry. The company's products and services include in vitro assay protocols, in vitro throughput screening and compound profiling services, custom assay development, enzymology services, and lead discovery/lead optimization partnering programs. It offers drug discovery contract research services, HTS, profiling and lead generation, and lead optimization solutions. The company serves pharmaceutical and biopharmaceutical companies, emerging biotechnology companies, and research foundations. Amphora Discovery Corporation was founded in 2001 and is headquartered in Durham, North Carolina. As of July 2008, Amphora Discovery Corporation operates as a subsidiary of Nanosyn Inc.

Total Funding Amount:

$94.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2001-01-01

Founders:

William Janzen

Number of Employees:

11-50

Last Funding Date:

2006-02-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai